Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2002 Sep;46(9):3084-7.
doi: 10.1128/AAC.46.9.3084-3087.2002.

Comparative evaluation of disk diffusion with microdilution assay in susceptibility testing of caspofungin against Aspergillus and Fusarium isolates

Affiliations
Comparative Study

Comparative evaluation of disk diffusion with microdilution assay in susceptibility testing of caspofungin against Aspergillus and Fusarium isolates

Sevtap Arikan et al. Antimicrob Agents Chemother. 2002 Sep.

Abstract

We compared the disk diffusion and broth microdilution methods for susceptibility testing of caspofungin against Aspergillus (n = 78) and Fusarium (n = 22) isolates. Microdilution testing followed the NCCLS M-38P guidelines but was performed in antibiotic medium 3 supplemented to 2% glucose (AM3). Disk diffusion assays were performed on AM3 agar plates with a 2- micro g caspofungin disk. By both methods, caspofungin showed favorable activity against Aspergillus isolates and no activity against Fusarium isolates. In the disk-based format, intrazonal growth that was not influenced by the drug concentration gradient was consistently observed for all of the Aspergillus isolates tested.

PubMed Disclaimer

Figures

FIG. 1.
FIG. 1.
Aspergillus growth pattern obtained by the disk diffusion test method. Note the clear zone edges and the microcolonies inside the IZ. The disk contained 2 μg of caspofungin.

References

    1. Arikan, S., M. Lozano-Chiu, V. Paetznick, and J. H. Rex. 2001. In vitro susceptibility testing methods for caspofungin against Aspergillus and Fusarium isolates. Antimicrob. Agents Chemother. 45:327-330. - PMC - PubMed
    1. Arikan, S., and J. H. Rex. 2000. New agents for treatment of systemic fungal infections. Emerg. Drugs 5:135-160. - PubMed
    1. Bartizal, K., T. Scott, G. K. Abruzzo, C. J. Gill, C. Pacholok, L. Lynch, and H. Kropp. 1995. In vitro evaluation of the pneumocandin antifungal agent L-733560, a new water-soluble hybrid of L-705589 and L-731373. Antimicrob. Agents Chemother. 39:1070-1076. - PMC - PubMed
    1. Beauvais, A., and J. P. Latge. 2001. Membrane and cell wall targets in Aspergillus fumigatus. Drug Resist. Update 4:38-49. - PubMed
    1. Cuenca-Estrella, M., E. Mellado, T. M. Diaz-Guerra, A. Monzon, and J. L. Rodriguez-Tudela. 2000. Susceptibility of fluconazole-resistant clinical isolates of Candida spp. to echinocandin LY303366, itraconazole and amphotericin B. J. Antimicrob. Chemother. 46:475-477. - PubMed

Publication types